The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic …

T Alsuliman, L Magro, V Coiteux, J Gauthier… - Current Research in …, 2020 - Elsevier
Therapeutic options are limited for patients developing refractory sclerotic-type chronic graft-
versus-host disease (cGVHD) after allogeneic hematopoietic cell transplantation. We …

[引用][C] 移植物抗宿主疾病皮肤损害的治疗进展

卢荣标, 陆春 - 器官移植, 2013

Comparative study of the phototoxicity of long-wavelength photosensitizers targeted by the MornigaG lectin

E Evangelio, G Poiroux, R Culerrier… - Bioconjugate …, 2011 - ACS Publications
Morniga G is a plant lectin selective for high density of tumor-associated carbohydrate T and
Tn antigens on the surface of cells. The interaction of the protein with Tn induces its cell …

Chemoirradiated neutrophils and T cells differentially affect immune functions of APCs

C Franklin, K Bruderek, B Schilling… - Journal of Leukocyte …, 2019 - academic.oup.com
Extracorporeal photopheresis (ECP) is known as an immunomodulatory therapy with few
side effects, which is mainly used in the treatment of cutaneous T cell lymphoma, graft …

[HTML][HTML] 慢性移植物抗宿主病研究进展

雷美清, 刘立民, 吴德沛 - Chinese Journal of Hematology, 2016 - ncbi.nlm.nih.gov
异基因造血干细胞移植(allo-HSCT) 是目前治疗造血系统恶性肿瘤, 某些遗传性及骨髓衰竭性
疾病的重要手段, 但移植物抗宿主病(GVHD) 仍是患者死亡的重要因素之一, 尤其慢性GVHD …

UV Treatment of Chronic Skin Graft-versus-Host Disease–Focus on UVA1 and Extracorporeal Photopheresis

HT Greinix, A Tanew - Transplantation Dermatology, 2012 - karger.com
Chronic graft-versus-host disease (GVHD) is a serious and life-threatening complication
after allogeneic hematopoietic stem cell transplantation. Cutaneous manifestations such as …

[HTML][HTML] Photosensitization by iodinated DNA minor groove binding ligands: evaluation of DNA double-strand break induction and repair

B Briggs, K Ververis, AL Rodd, LJL Foong… - … of Photochemistry and …, 2011 - Elsevier
Iodinated DNA minor groove binding bibenzimidazoles represent a unique class of UVA
photosensitizer and their extreme photopotency has been previously characterized. Earlier …

Indications for therapeutic apheresis in hematological disorders

ZM Szczepiorkowski - Seminars in hematology, 2020 - Elsevier
The early apheresis devices were developed in 1930s, but therapeutic apheresis only
became widely used decades later, when automated cell separators were introduced …

К эффективности фотофереза при анетодермии

ВА Молочков, ОВ Карзанов… - … журнал кожных и …, 2013 - cyberleninka.ru
Статья посвящена лечению анетодермии методом экстракорпоральной
фотохимиотерапии—фотоферезом (ФФ). Мы наблюдали выраженный клинический …

Call It BOS, Call It CLAD—The Need for Prospective Clinical Trials and Elucidating the Mechanism of Extracorporeal Photopheresis

ML Barr - American Journal of Transplantation, 2013 - Wiley Online Library
In the context of the promising results seen in the article by Greer et al (page 911), and with
the failure of most conventional immunosuppressive agents to have any impact on the …